Coen Steven P.'s most recent trade in Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A was a trade of 1,174 Restricted Stock Units done . Disclosure was reported to the exchange on July 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,174 | 5,883 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 1,174 | 51,878 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 16 Jul 2026 | 752 | 51,438 | - | 7.9 | 5,943 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 312 | 3,131 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 312 | 52,190 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 587 | 50,855 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 587 | 7,057 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 21 May 2026 | 307 | 50,704 | - | 8.3 | 2,559 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 156 | 51,011 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 156 | 3,443 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 587 | 50,436 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 587 | 7,644 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 7.95 per share. | 16 Apr 2026 | 324 | 50,268 | - | 8.0 | 2,576 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 156 | 3,599 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 156 | 50,592 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 45,553 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 45,553 | 83,020 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 10 Apr 2026 | 33,171 | 49,849 | - | 6.4 | 212,759 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 28,368 | 37,467 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 28,368 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 1,174 | 9,495 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 1,174 | 8,231 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 6.73 per share. | 13 Mar 2026 | 708 | 9,099 | - | 6.7 | 4,768 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 312 | 9,807 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 312 | 3,755 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 1,062 | 9,293 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 1,062 | 0 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 8.92 per share. | 16 Jan 2026 | 972 | 8,321 | - | 8.9 | 8,667 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 587 | 8,075 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 587 | 9,405 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 156 | 8,231 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 156 | 4,067 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 1,174 | 7,912 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 1,174 | 9,992 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 8.89 per share. | 12 Dec 2025 | 736 | 7,488 | - | 8.9 | 6,540 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 312 | 4,223 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 312 | 8,224 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 13.65 per share. | 16 Oct 2025 | 1,312 | 6,738 | - | 13.6 | 17,907 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 1,174 | 11,166 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 1,174 | 6,677 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 1,061 | 1,062 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 1,061 | 8,050 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 312 | 4,535 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 312 | 6,989 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 01 Oct 2025 | 5,609 | 5,503 | - | 15 | 84,135 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 587 | 11,266 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 587 | 12,340 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 21 Aug 2025 | 310 | 11,112 | - | 12.4 | 3,843 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 156 | 4,847 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 156 | 11,422 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 1,174 | 10,390 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 1,174 | 12,927 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 9.84 per share. | 16 Jul 2025 | 1,084 | 10,679 | - | 9.8 | 10,669 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 1,061 | 2,123 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 1,061 | 11,763 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 312 | 5,003 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 312 | 10,702 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 587 | 9,406 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 587 | 14,101 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 20 May 2025 | 346 | 9,216 | - | 7.6 | 2,624 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 156 | 9,562 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 156 | 5,315 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 1,061 | 9,816 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 1,061 | 3,184 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 17 Apr 2025 | 997 | 8,819 | - | 7.3 | 7,261 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 587 | 14,688 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 587 | 8,599 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 156 | 8,755 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 156 | 5,471 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 4,245 | 4,245 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 587 | 8,251 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 587 | 15,275 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 7.72 per share. | 03 Mar 2025 | 395 | 8,012 | - | 7.7 | 3,051 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 156 | 5,627 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 156 | 8,407 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 587 | 7,875 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 587 | 15,862 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 13.44 per share. | 03 Feb 2025 | 367 | 7,664 | - | 13.4 | 4,934 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 156 | 5,783 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 156 | 8,031 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 587 | 16,449 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 587 | 7,456 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 03 Jan 2025 | 324 | 7,288 | - | 11.7 | 3,797 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 156 | 7,612 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 156 | 5,939 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | P. Steven Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 587 | 17,036 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven Coen P. | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 587 | 7,043 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven Coen P. | See remarks | Sale of securities on an exchange or to another person at price $ 9.65 per share. | 03 Dec 2024 | 330 | 6,869 | - | 9.6 | 3,183 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Coen Steven P. | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 156 | 6,095 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | P. Coen Steven | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 156 | 7,199 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 587 | 17,623 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 587 | 6,633 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 01 Nov 2024 | 333 | 6,456 | - | 7.6 | 2,523 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 156 | 6,251 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 156 | 6,789 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 587 | 18,210 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 587 | 6,196 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Sale of securities on an exchange or to another person at price $ 8.35 per share. | 03 Oct 2024 | 306 | 6,046 | - | 8.3 | 2,555 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 156 | 6,352 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 156 | 6,407 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Steven P. Coen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 587 | 5,769 | - | - | Class A Common Stock |